Research Network Pharmacist

It’s More Than a Career, It’s a Mission.

Our people are the foundation of our success. By joining our growing team at Sarah Cannon Research Institute (SCRI), a subsidiary of McKesson, you will have the opportunity to become part of one of the largest community-based cancer programs to advance oncology treatments and improve outcomes for cancer patients across the globe. We look for mission-driven candidates who have a desire to advance the fight against cancer and make a difference in the lives of patients diagnosed with cancer every day.

Our Mission

People who live with cancer - those who work to prevent it, fight it, and survive it - are at the heart of every decision we make. Bringing the most innovative medical minds together with the most passionate caregivers in their communities, we are transforming care and personalizing treatment. Through clinical excellence and cutting-edge research, SCRI is redefining cancer care around the world.

As the Research Site Support Pharmacist you will lead in the development and maintenance of clinical trial regimen templates (electronic order sets) to support technology platforms and clinical research. You will review oncology clinical trial protocols and trial documents to verify electronic order sets are created accurately. This includes composition of content language, investigational agent preparation and administration, standard of care administration, and supplemental treatment (premedication, supportive care, etc.).

• You will d evelop clinical content for electronic order sets for iKnowMed ( iKM ) SCRI investigational drug trials.
• You will serve as a clinical resource to review SCRI protocols and develop clinical content of electronic order sets for iKM . You will c ollaborate with the Research Operations Team, Clinical Informatics Team, and National Principal Investigator (NPI) as necessary.
• You will compose and maintain electronic order set content per protocol specifications for all protocols prior to study opening. Ensures iKM regimen order sets are consistent with protocol requirements.
• You will compose and maintain electronic order sets content for all actively enrolling clinical trial protocol amendments which require a change in the original iKM regimen order set to ensure changes are made in accordance with the protocol amendment. You will e nsure that the iKM regimen order set is referenced with the accurate protocol version and date.
• You will review electronic order sets for alignment with approved SCRI standardization when appropriate per clinical trial protocol guidance.
• You will serve as SCRI lead for Research Operations Council (ROC) Community of Practice for Pharmacy.
• You will f acilitate communication among SCRI network site pharmacists to identify issues and solutions that improve the continuity of investigational drug management for SCRI clinical trials.
• You will effectively communicate internally and externally with key stakeholders to SCRI for the effective building of regimen order sets.
• You will f acilitate rapport between the Clinical Informatics and the central SCRI department and trial sponsors related to development of accurate regimen order sets.
• You will consult with other pharmacy and / or clinical personnel, to obtain information / expertise in support of the investigational drug trials and network standards, as required .
• You will be a vailable as a resource for community oncology research sites or internal stakeholders for education on trial specifics, and drug information related to investigational trial drugs.
• You will conduct training sessions with SCRI staff on clinical trial iKM regimen order sets. This training includes but is not limited to : iKM regimen checklist completion, checklist submission process, and regimen review and approval.

You should have for this position :

About Sarah Cannon Research Institute

Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country. It has conducted more than 750 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. SCRI’s research network brings together more than 1,300 physicians who are actively enrolling patients into clinical trials at more than 250 locations in 24 states across the U.S. Please click here to learn more about our research offerings.

We care about the well-being of the patients and communities we serve, and that starts with caring for our people. That’s why we have a Total Rewards package that includes comprehensive benefits to support physical, mental, and financial well-being. Our Total Rewards offerings serve the different needs of our diverse colleague population and ensure they are the healthiest versions of themselves. For more information regarding benefits through our parent company, McKesson, please click here .

As part of Total Rewards, we are proud to offer a competitive compensation package. This is determined by several factors, including performance, experience and skills, equity, regular job market evaluations, and geographical markets. In addition to base pay, other compensation, such as an annual bonus or long-term incentive opportunities may be offered.

We are an equal opportunity employer and value diversity at our company. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.